Compounds for central reactivation of organophosphorus-based compound-inhibited acetylcholinesterase and/or inactivation of organophosphorus-based acetylcholinesterase inhibitors and related compositions methods and systems for making and using them
Patent
·
OSTI ID:1860113
Described herein are oxime compounds capable of inactivating OP-based AChE inhibitors, crossing the blood brain barrier (BBB), and/or reactivation of OP-inhibited acetylcholinesterase (AChE) and related methods, systems and compositions for inactivation of one or more OP-based AChE inhibitors, therapeutic and/or prophylactic treatment of an individual, and/or decomposition of OP-based AChE inhibitors for decontamination.
- Research Organization:
- Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-07NA27344
- Assignee:
- Lawrence Livermore National Security, LLC (Livermore, CA)
- Patent Number(s):
- 11,186,548
- Application Number:
- 16/198,627
- OSTI ID:
- 1860113
- Resource Relation:
- Patent File Date: 11/21/2018
- Country of Publication:
- United States
- Language:
- English
Similar Records
Compounds for reactivation of acetylcholinesterase and related compositions methods and systems
The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs
Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro
Patent
·
Tue Mar 17 00:00:00 EDT 2020
·
OSTI ID:1860113
+6 more
The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs
Journal Article
·
Thu Sep 21 00:00:00 EDT 2017
· Chemico-Biological Interactions
·
OSTI ID:1860113
+9 more
Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro
Journal Article
·
Sun May 15 00:00:00 EDT 2011
· Toxicology and Applied Pharmacology
·
OSTI ID:1860113
+3 more